Filing Flows › Opko Health (OPK) › Guidance & outlook
Opko Health (OPK) guidance and outlook
Opko Health (OPK) raised some and lowered other parts of its guidance on Nov 4, 2026: Revenue $41.0M for FY2026; Gross profit $12.5M for FY2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $41.0M | lowered |
| Gross profit | FY2026 | $12.5M | raised |
From the earnings release filed Nov 4, 2026 (8-K on EDGAR).
Opko Health's latest quarter
Opko Health, Q3 2026: revenue $65.4M (+16% year over year), operating margin -48.0%, net loss $53.5M, operating cash flow −$36.3M. The chart follows the revenue to costs, profit and cash.
Questions
Did Opko Health raise or lower its guidance?
Opko Health (OPK) raised some and lowered other parts of its guidance on Nov 4, 2026: Revenue $41.0M for FY2026; Gross profit $12.5M for FY2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.